Trials / Terminated
TerminatedNCT04578951
Measurement of the Quality of Life in Patients Operated With a Total Knee Prosthesis (TKA) From the FHK® Range.
Measurement of the Quality of Life in Patients Operated With a Total Knee Prosthesis (TKA) From the FHK® Range and Followed for 2 Years.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- FH ORTHO · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
As part of Medical Devices CE marking regulatory process, an appropriate post-market clinical follow-up (PMCF) is required. This PMCF study is in the framework of CE mark renew of FHK® total knee prosthesis, it aims to answer specific questions related to safety and performance of the device, when used in accordance with the approved instructions for use. This study is based on a quality of life self-assessment from the preoperative to postoperative phases and up to two years of follow-up.
Detailed description
The primary objective of this study is to evaluate the quality of life in patients operated with a FHK® total knee prosthesis up to 2 years of follow-up. The secondary objectives are to evaluate the security and performance of the devices by gathering complications, revision rate of the devices (survival analysis) and functional score up to 2 years of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FHK® total knee prosthesis | FHK® prosthesis are intended to be implanted in the tibial and femoral regions during total knee arthroplasty in order to restore joint function. |
Timeline
- Start date
- 2020-09-28
- Primary completion
- 2023-03-30
- Completion
- 2023-03-30
- First posted
- 2020-10-08
- Last updated
- 2023-11-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04578951. Inclusion in this directory is not an endorsement.